• Active Medical Xcellence secured seven-figure growth financing led by bm-t beteiligungsmanagement thüringen through Thüringer WachstumsBeteiligungsFonds II.
• Other investors included MBG Thüringen, Sparkasse Jena-Saale-Holzland and a business angel.
• The Jena-based company develops medical devices for urological endoscopy, including the MDR-approved activeCut morcellator for treating benign prostatic obstruction.
• Proceeds will support sales expansion, international growth and technology platform development, including faster activeCut commercialization in Europe and selected international markets.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bm T Beteiligungsmanagement published the original content used to generate this news brief on November 09, 2026, and is solely responsible for the information contained therein.